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Abstract
Based on the observation that an internally located 3 promoter sequence can be functional (R. Flick and G. Hobom, Virology, 1999,
262(1), 93–103), we generated transfectant influenza A viruses harboring a dicistronic segment containing the CAT gene (660 nt) or a
fragment of the Mengo virus VP0 capsid gene (306 nt) under the control of a duplicated 3 promoter sequence. Despite slightly reduced
NA expression, the transfectant viruses replicated efficiently and proved to be stable upon both serial passage in vitro in MDCK cells and
in vivo replication in the pulmonary tissue of infected mice. Internal initiation of replication and transcription from the second, internal, 3
promoter directed the synthesis of subgenomic vRNA and mRNA and therefore permitted expression of the foreign gene product, e.g., the
CAT enzyme. The design of this vector may prove particularly appropriate for the utilization of influenza virus for the expression of
heterologous proteins in their native form.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Influenza A viruses are enveloped negative-strand RNA
viruses belonging to the family Orthomyxoviridae. Their
genome consists of eight different single-stranded RNA
segments (vRNA), of which replication takes place in the
nucleus of infected cells. In virions and infected cells, the
vRNAs are present in the form of ribonucleoproteins
(RNPs) as they are encapsidated by nucleoprotein (NP)
molecules and associated with the viral polymerase com-
plex. The latter is a heterotrimer formed by the PB1, PB2,
and PA molecules, which ensures both transcription and
replication of the vRNAs. The replication process involves
the synthesis of a full-length RNA copy of positive polarity
(cRNA), which in turn serves as a template for the synthesis
of new vRNA molecules. As for vRNA, cRNA is found in
the form of RNPs in the infected cells (for a review, see
Lamb and Krug, 2001).
Unlike cRNA or vRNA synthesis, which is initiated in a
primer-independent fashion during the replication process,
the transcription of viral mRNA is initiated by a cap-snatch-
ing mechanism (Krug et al., 1979). The nascent mRNA
molecules are elongated by copying the vRNA template
from its 3 end to a termination and polyadenylation signal
consisting of a poly(U) sequence of five to seven residues,
located close to its 5 end (Luo et al., 1991; Poon et al.,
1999; Pritlove et al., 1998). The RNA signals controlling
replication and packaging of the vRNAs or transcription and
polyadenylation of the viral mRNAs are known to be lo-
cated within the 5 and 3 terminal noncoding regions
(NCR) of the vRNA (Luytjes et al., 1989). At the 5 and 3
extremities, the first 13 and 12 conserved nucleotides, re-
spectively, are almost identical among all eight vRNA seg-
ments. They interact together to form a partially double-
stranded “corkscrew” structure, which constitues the vRNA
promoter for cRNA and mRNA synthesis (Flick et al.,
1996). Adjacent to these conserved sequences, noncon-
served noncoding sequences of 7 to 45 nucleotides are
believed to be involved in the regulation of the replication
and transcription processes (Bergmann and Muster, 1996;
Zheng et al., 1996). A single mRNA species is produced
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from each vRNA segment, allowing the expression of one
viral protein per segment, with the exception of the PB1, M,
and NS segments. These encode an additional protein either
through the use of an alternate start codon (PB1-F2 protein)
(Chen et al., 2001) or through an alternate splicing mecha-
nism (M2 and NS2 proteins, respectively) (Inglis et al.,
1979; Lamb and Choppin, 1979; Lamb et al., 1981).
The segmented nature of the influenza genome and the
essentially monocistronic nature of each segment has
hampered the development of influenza viruses as vectors
for the expression of foreign sequences. However, during
the last decade, the development of reverse genetics tech-
niques (for a review, see Neumann and Kawaoka, 2002)
has allowed to explore several approaches for the gener-
ation of recombinant influenza viruses and enabled to
express heterologous protein sequences. In a first ap-
proach, the hemagglutinin (HA) or the neuraminidase
(NA) have been used as carriers of short foreign polypep-
tide sequences in transfectant influenza viruses (Ca-
strucci et al., 1992; Li et al., 1993). This strategy was
limited to the use of small-size epitope inserts, up to 12
amino acids in the antigenic site B or E of the HA (as
reported in Gonzalo et al., 1999; Rodrigues et al., 1994)
and up to 28 amino acids in the stalk of the NA (as
reported in Castrucci and Kawaoka, 1993). Also, depend-
ing on the foreign epitope insert, alterations of the struc-
ture and hence the function of the carrier protein may
prevent the generation of viable recombinant viruses.
In a second approach, much longer polypeptides were
expressed by means of a fusion protein containing an
autocatalytic cleavage site between an essential viral
gene product and the foreign polypeptide (Ferko et al.,
2001; Percy et al., 1994). However, this approach results
in the expression of altered viral and/or foreign proteins
due to the presence of the remaining cleavage site se-
quences. Alternatively, vRNA segments with additional
translational units have been engineered by the use of an
internal ribosome entry site (IRES). Following this ap-
proach, the A/WSN/33 (WSN) virus NA segment was
made dicistronic at the level of mRNA translation by
insertion of the IRES of the human BiP mRNA between
a foreign and the NA openreading frames (ORFs) (Gar-
cia-Sastre et al., 1994a). In this case, a single dicistronic
mRNA species directs the translation of the foreign pro-
tein from the first ORF by a cap-dependent mechanism,
whereas translation of the NA coding sequences occurs
via internal binding of the ribosomes to the IRES.
Yet another approach relied on the replication and pack-
aging by wild-type influenza viruses of a ninth synthetic and
independent, pseudoviral RNA segment composed of a for-
eign ORF, in negative-sense orientation, flanked by the
terminal 5 and 3 promoter sequences (Luytjes et al., 1989;
Neumann et al., 1994). However, the rescue of such a
synthetic RNA segment by influenza virus was only tran-
sient and the ninth segment is usually lost upon a few
passages, although, recently, the use of 3 promoter mutants
with higher replication levels allowed this type of nones-
sential segment to be maintained in the viral progeny for
more than 10 passages (Neumann and Hobom, 1995; Zhou
et al., 1998).
Flick and Hobom demonstrated the ability of the in-
fluenza virus polymerase complex to recognize internally
located 5 and 3 promoters (Flick and Hobom, 1999).
Using this feature, they introduced a new principle for the
construction of dicistronic vRNAs by showing that a
recombinant vRNA-like molecule, which contained two
reporter gene ORFs [e.g., chloramphenicol acetyl trans-
ferase (CAT) and green fluorescent protein (GFP)], and
an additional 3 promoter sequence located in between,
could be transcribed and replicated following two modes,
after interaction of the single 5 promoter sequence with
either of the two 3 promoter sequences. Two types of
mRNA molecules were thus produced: genomic mRNA
allowed translation of the proximal cistron (e.g., GFP),
whereas the shorter subgenomic mRNA drove the trans-
lation of the second, distal cistron (e.g., CAT). More
recently, Azzeh et al. (2001) reported another variation
for the design of dicistronic vRNA-like molecules: in this
last approach, they showed that a recombinant vRNA-
like molecule could be constructed with two reporter
genes arranged in an ambisense genetic organization in
such a way that the two gene products were translated
from two complementary mRNAs.
In this article, we explored the possibility of rescuing
transfectant influenza A viruses harboring, in a stable
manner, a dicistronic segment with a foreign gene under
the control of a duplicated 3 promoter. As a model, we
constructed a dicistronic segment by inserting a second 3
promoter sequence and the sequences encoding the CAT
enzyme (219 aa), in negative-sense orientation, between
the NA-coding sequences and the 5 promoter sequence
of vRNA segment 6 of the WSN influenza virus. In this
construct, the NA coding sequences were located at the
3-proximal position, which ensured that the full-length
dicistronic vRNA segment would be maintained during
propagation of the recombinant virus because NA expres-
sion was essential for its viability. Indeed, a transfectant
virus with such a dicistronic NA-CAT segment was res-
cued and we demonstrated that internal initiation of tran-
scription from the second 3 promoter directed the syn-
thesis of subgenomic vRNA and mRNA, which resulted
in expression of the CAT enzyme. Moreover, this virus
proved to be stable upon both serial passage in vitro and
replication in the pulmonary tissue of infected mice.
Similar constructs allowed rescue of viruses carrying a
shorter reporter gene coding for a fragment of Mengo
virus VP0 capsid protein (101 aa) but not of viruses
carrying the longer GFP sequences (239 aa), suggesting
the existence of constraints on the size or the nature of
the inserted foreign sequences.
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Results
CAT expression by dicistronic recombinant vRNA-like
molecules carrying a duplicated 3 promoter sequence
Based on the ability of the influenza polymerase complex
to recognize an internally located 3 promoter (Flick and
Hobom, 1999), we explored the possibility of expressing
foreign sequences by means of a genomic segment contain-
ing a duplicated and internally located 3 promoter. We used
the NA segment of WSN virus since reverse genetics of this
segment is simple and very efficient (Pleschka et al., 1996)
to derive the NA35 series of dicistronic vRNA-like mole-
cules. As described under Materials and methods, the cDNA
of these molecules were cloned, in negative-sense orienta-
tion, in plasmid pPR7 downstream of the truncated human
RNA polymerase I promoter and upstream of the ribozyme
sequence of the hepatitis  virus (Crescenzo-Chaigne et al.,
1999). A duplication of the 19 nucleotides of the 3 non-
coding region (3 promoter sequence) together with an
XhoI-NheI multiple cloning site (MCS) were inserted be-
tween the stop codon and the 5 promoter sequence of the
WSN NA segment (Fig. 1). Subsequently, three reporter
genes of various sizes were inserted into the MCS: the CAT
gene (660 nt), the GFP gene of Aequorea victoria (720 nt),
and a sequence coding for a fragment of the VP0 protein of
Mengo virus (VP0c, 306 nt). Thus, the pPR-NA35 plasmid
series direct the synthesis of vRNA-like molecules, which
contain the NA ORF of WSN downstream of the original 3
promoter and a second ORF (CAT, GFP, or Vp0c) down-
stream of the duplicated 3 promoter, followed by the 5
promoter of the NA RNA segment of WSN. The control
pPR-NA37 plasmid series, which directs the synthesis of
dicistronic vRNA-like molecules from which the internal 3
promoter sequence has been deleted, was constructed in
parallel.
To determine whether the duplicated 3 promoter would
be recognized in its internal location as could be expected
from previously published work (Flick and Hobom, 1999),
transient expression assays were performed after in vivo
reconstitution of functional vRNPs. COS-1 cells were trans-
fected with the pPR-NA35-CAT plasmid together with the
four polymerase II (pol II) expression plasmids pcDNA-
PB1, pcDNA-PB2, pcDNA-PA, and pcDNA-NP and North-
ern blot analysis was performed on total RNA extracted
48 h later. After hybridization to a positive-sense riboprobe
Fig. 1. Schematic representation of transfer plasmids for the synthesis of dicistronic NA vRNA segments derived from the A/WSN/33 influenza virus. Plasmid
pPR-NA35 was derived from plasmid pPR-NA, which contains the full-length NA segment cDNA in negative-sense orientation under the control of a
truncated human pol I promoter, as described under Materials and methods. It contains a recombinant NA segment cDNA, in which the NA ORF is followed
by a duplicated 3 promoter, an XhoI/ NheI linker, and the original 5 promoter. The VP0c, CAT, or GFP ORF sequences were inserted between the XhoI
and NheI restriction sites, yielding plasmids pPR-NA35-VP0c, -CAT, and -GFP, respectively. The pPR-NA37 plasmid was derived from pPR-NA35 by
deletion of the duplicated 3 promoter sequence. P-pol1:truncated human polymerase I promoter (254 to1 nucleotides). HDV-R:hepatitis  virus genomic
ribozyme.
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specific for CAT sequences, two RNA species could be
detected (Fig. 2A): they corresponded in size to the full-
length NA35-CAT vRNA-like molecule (2104 nt) and to a
shorter subgenomic molecule constituted by the CAT gene
sequences flanked by 5 and 3 noncoding sequences (719
nt). Similar analyses performed with a negative-sense ribo-
probe allowed the detection of full-length genomic cRNA
and mRNA and shorter subgenomic cRNA and mRNA (Fig.
2B). As shown in Fig. 2C, high levels of CAT expression
were also measured in cytosolic extracts from these trans-
fected cells (120 ng/106 cells). Neither subgenomic RNA
molecules nor consistent CAT expression were observed
when the internal 3 promoter was deleted from the dicis-
tronic molecule (NA37-CAT construct). This proved the
absence of internal initiation of subgenomic RNAs from
genomic vRNA or cRNA molecules lacking an internal
promoter element. Residual CAT protein expressed from
NA37-CAT molecules (1.5 ng/106 cells) was interpreted as
a read-through of the NA ORF stop codon and was consis-
tent with the fact that the CAT initiating methionine was
in-frame with the NA ORF in this construct.
Similar results were obtained with pPR-NA35-GFP and
pPR-NA35-VP0c plasmids, both at the level of vRNA when
Northern blots were performed with appropriate probes and
at the level of expression, when GFP expression was mea-
sured by cytofluorometry at 530 nm (data not shown). In
parallel, NA expression was also revealed for the three
NA35, NA35-CAT, and NA35-VP0c constructs by flow
cytometry analysis of transfected cells after labeling with
monoclonal antibody 10C9 directed against the WSN NA
(data not shown).
These results suggest that the dicistronic NA35-CAT
vRNA molecules were replicated and transcribed by the
influenza RNA polymerase complex according to two dif-
ferent modes, a genomic and a subgenomic mode. After
interaction of the unique 5 promoter with the external 3
promoter, the first mode allowed replication of the full-
length (genomic) dicistronic RNA molecule, transcription
of a full-length mRNA, and therefore, expression of the NA
gene product. Alternatively, interaction of the 5 promoter
with the duplicated internal 3 promoter resulted in replica-
tion of a subgenomic RNA molecule in which the CAT
ORF sequences were flanked by the 5 and 3 promoter, and
in transcription of the corresponding subgenomic mRNA
from which CAT was expressed.
Rescue of transfectant WSN viruses with dicistronic NA
segments
Reporter gene and NA expression suggested that dicis-
tronic molecules of the NA35 series could be used for the
construction of transfectant influenza viruses containing a
dicistronic segment. Indeed, following vRNP reconstitution
in COS cells simultaneously infected with the WSN-HK
helper virus as described by Pleshka et al. (1996), the
NA35-CAT and NA35-VP0c RNAs could be rescued into
infectious viruses, which were able to form plaques on
Madin–Darby bovine kidney (MDBK) cells. It is notewor-
thy that the efficiency of rescue of these transfectant viruses
harboring a dicistronic NA segment (vNA35-CAT and
vNA35-VP0c) was markedly reduced when compared with
that of a wild-type virus harboring a monocistronic WSN
NA segment. In several independent reverse genetics ex-
periments, using the wild-type NA segment, infectious
WSN (vNA) viruses were rescued up to titers of 105 to 106
PFU/ml, whereas titers of only 101 PFU/ml (vNA35-CAT)
Fig. 2. Transient expression of the CAT gene from the recombinant
dicistronic NA35-CAT RNA. Subconfluent monolayers of COS-1 cells
were transfected by a mixture of plasmids pcDNA-NP, pcDNA-PA,
pcDNA-PB1, and pcDNA-PB2, together with each of the pol I expression
plasmids indicated and then incubated at 35°C, as described under Mate-
rials and methods. At 48 h posttransfection, total cellular RNA was pre-
pared and analyzed by Northern blot for the presence of negative-sense
genomic and subgenomic vRNAs (A) or for the presence of positive-sense
cRNAs or mRNAs (B) with positive-(A) or negative-(B) sense 32P-labeled
riboprobes specific for CAT sequences, prior to exposure on a Storm
phosphorimager (Molecular Dynamics). Positions of genomic (closed ar-
rowheads) and subgenomic (open arrowheads) RNAs and of molecular
weight markers (kb) are indicated. In parallel, cytosolic cell extracts were
prepared at 48 h post transfection and assayed for CAT levels (C). Levels
are given in nanograms of CAT protein for 106 transfected cells.
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or 102 to 103 PFU/ml (vNA35, vNA35-VP0c) were ob-
tained for transfectant viruses with dicistronic segments.
Despite numerous attempts, the dicistronic NA35-GFP
RNA was never rescued into infectious virus. The transfec-
tant viruses were plaque purified twice on MDBK cells and
several independent clones were selected for further char-
acterization.
Characterization of vNA35-CAT and vNA35-VP0c
transfectant viruses
The plaque phenotype of the transfectant viruses was
evaluated in Madin–Darby canine kidney (MDCK) cells
under an agarose overlay in the absence of an exogeneous
source of protease, but in the presence of 2% FCS. No
significant differences were observed between the plaque
size of wild-type WSN (vNA) virus and vNA35, a trans-
fectant virus with a duplication of the 3 promoter but no
insertion of foreign sequences. In contrast, the vNA35-
VP0c virus gave slightly smaller plaques and vNA35-CAT
definitely gave medium-sized plaques (Fig. 3A). Similar
results were obtained when plaque assays were performed
on MDBK cells (data not shown), suggesting that the rep-
lication of the dicistronic viruses could be impaired.
To determine whether the efficiency of multiplication of
the dicistronic viruses was altered, growth kinetics were
performed on MDCK cells and compared with those of the
wild-type vNA and the vNA35 viruses. A representative
experiment is shown in Fig. 3B, but similar results were
obtained for the other viral clones. The maximum yields of
both vNA35 and vNA35-VP0c viruses were reached 48 h
after infection with viral titers that were about 0.5 and 1
log10 unit lower than that of wild-type vNA virus (109
PFU/ml), respectively. In contrast, the growth rate of the
vNA35-CAT virus was significantly lower, with titers
reaching the level of 107 PFU/ml only (Fig. 3B). This was
in agreement with the smaller plaque phenotype of the
vNA35-CAT virus. Thus, despite an elongated NA segment
and a duplicated 3 promoter, dicistronic viruses were ca-
pable of replicating efficiently in MDCK and MDBK cells.
To confirm the presence of the dicistronic segments in
the rescued transfectant viruses, viral RNA was extracted
from working stocks at passage p1 and subjected to RT-
PCR analysis, as described under Materials and methods.
With primers NA//1085 and NA/NC/5 designed to am-
plify the whole region of insertion and located, respectively,
in the NA ORF and 5 promoter, amplified fragments of the
expected size were observed for all clones analyzed (Fig.
3D). Direct sequencing of all these PCR products demon-
strated that the duplicated 3 promoter and the entire CAT
or VP0c sequences were present and identical to those of the
plasmids from which the viruses were derived. In addition,
RACE analysis of the 5 and 3 termini of the NA segment
vRNAs indicated that external noncoding regions of the
rescued dicistronic viruses were identical to those of wild-
type WSN virus (vNA), with the exception of vNA35-CAT
clone 2 which exhibited an A-to-G mutation at position 17
of the genomic 3 NCR (data not shown).
To evaluate the genetic stability of the vNA35-CAT and
vNA35-VP0c dicistronic viruses, several clones of each
virus were serially passaged five or six times on MDCK
cells at a low m.o.i. and their NA segment vRNA was
analyzed by RT-PCR as for the first passage (Fig. 3D). No
evidence of deletion of the VP0c-inserted sequences could
be observed for the three vNA35-VP0c clones tested,
whereas a fragment of a slightly smaller size was identified
for one of three vNA35-CAT clones (clone 2) at p5. Se-
quencing of the corresponding PCR product revealed a
small in-frame deletion of 30 nucleotides in the CAT ORF.
Sequencing of all the other PCR products revealed only two
more mutations found in the CAT ORF of vNA35-CAT
clone 3: a U3 C change at position 602 (Val3 Ala) and a
G 3 A change at position 652 (Gly3 Arg). To further
evaluate genetic stability, one clone of each virus was fur-
ther passaged up to p10 on MDCK cells. Each of the viruses
was found to have retained the inserted sequences when
their NA segment was subjected to RT-PCR analysis as
described above (data not shown).
Since Fodor et al. showed that the impaired growth
properties of some mutated WSN viruses were due to re-
duced levels of neuraminidase expression (Fodor et al.,
1998), we examined NA expression by the dicistronic vi-
ruses described above. MDCK cells were infected with
wild-type WSN (vNA) or dicistronic vNA35, vNA35-VP0c,
or vNA35-CAT viruses at an m.o.i. of 2 and, 8 h later, NA
expression at the cell surface was determined by FACS
analysis, as described under Materials and methods. As
shown in Fig. 3C, cells infected with dicistronic vNA35-
VP0c or vNA35-CAT viruses showed, respectively, a 54
and 71% reduction in NA expression as compared to cells
infected with vNA, whereas cells infected with vNA35 or
vNA expressed similar amounts of NA (not shown). These
reduced levels of NA expression could account for the
impaired growth properties of the dicistronic viruses. In
addition, we observed that the growth properties of the
vNA37-CAT virus, similar in design to vNA35-CAT but
with a deletion of the 3 internal promoter, were at least as
impaired as those of vNA35-CAT. Indeed vNA37-CAT
grew to low titers (106 PFU/ml) and gave small-to-medium-
sized plaques on MDCK cells (Fig. 3E). This observation
suggested that the impaired growth properties of the dicis-
tronic virus mainly resulted from the insertion of foreign
sequences into their NA segment rather than from compe-
tition of the duplicated 3 internal promoter with the 3
external promoter for interaction with the single 5 pro-
moter.
NA-specific RNA levels in cells infected with the
dicistronic viruses
MDCK cells were infected with wild-type WSN (vNA)
or dicistronic vNA35, vNA35-VP0c, or vNA35-CAT vi-
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ruses at an m.o.i. of 2 and total RNA was isolated from cells
at 8 h postinfection. NA-specific vRNA and cRNA/mRNA
levels were analyzed by Northern blot using the NP gene as
an internal control. Although the amount of NP vRNA was
similar in dicistronic and wild-type vNA virus-infected
cells, the amount of NA vRNA was about 13 times lower in
vNA35-CAT-infected cells and 3 times lower in vNA35-
VP0c-infected cells as determined by phosphorimager anal-
ysis (Fig. 4A). Similar results were obtained when cRNA/
mRNA levels were analyzed (Fig. 4B). Whether these
reduced NA RNA levels resulted from a decrease in NA
RNA synthesis or from a decrease in RNA stability remains
to be determined. However, as the reduction of RNA levels
was most pronounced in the case of vNA35-CAT, it seems
more likely that the overall efficiency of vRNA, cRNA, and
mRNA synthesis of the NA segment might be diminished as
a result of the increased length of the corresponding tem-
plates.
Analysis of viral RNA and CAT expression by the
dicistronic vNA35-CAT virus
Since NA expression is required for viral infectivity in
MDBK cells, the viability and genomic characteristics of
the recombinant dicistronic viruses (see above) demon-
strated that the viral polymerase complex expressed in the
course of influenza virus infection was able to replicate and
transcribe the recombinant dicistronic RNA according to the
genomic mode, which allowed propagation of the genetic
information of the recombinant virus.
To confirm that the polymerase complex expressed in the
context of infected cells was also able to transcribe and
replicate the dicistronic RNA according to the subgenomic
mode, Northern blot analysis was performed on total RNA
extracted from COS-1 cells, infected with recombinant
vNA35 or two independant clones of vNA35-CAT. As for
the transient expression assay, two vRNA-like species could
be detected with a CAT-specific riboprobe, vRNA-like mol-
ecules of full-length genomic size, and shorter subgenomic
molecules (Fig. 5A). Genomic and subgenomic cRNA/
mRNA were also detected with a negative-sense CAT-
specific riboprobe (Fig. 5B). It is noteworthy that the sub-
genomic RNAs were far less abundant than the full-length
dicistronic genomic RNAs, suggesting that they were less
efficiently replicated when the influenza polymerase com-
plex was expressed following infection rather than recon-
stituted following transfection of the plasmids expressing
the four core proteins (compare with Fig. 2A).
Next, the CAT production was examined in extracts of
COS-1 cells infected at an m.o.i. of 2 with the dicistronic
vNA35 or vNA35-CAT viruses. Expression of CAT was
detected in infected cells at 8 h postinfection (1.8  0.7
ng/106 cells) and increased with time up to 24 h postinfec-
tion (11.6  5.0 ng/106 cells), when cells began to show a
typical cytopathic effect (Fig. 5C).
Similarly, low ratios of subgenomic-to-genomic RNAs
were observed in cells infected with the vNA35-VP0c virus
but, presumably due to the poor sensitivity of poly-histi-
dine-tagged protein detection by Western blot, we have
been unable to detect expression of the Mengo virus VP0c
polypeptide in infected cells.
Dicistronic vNA35-VP0c virus replicates efficiently in
mice
We next examined the potential of the dicistronic
vNA35-VP0c virus to replicate in the respiratory tract of
C57BL/6 mice. Male mice were inoculated intranasally
under light ketamine anesthesia with 103 PFU of wild-type
WSN (vNA) or dicistronic vNA35 or vNA35-VP0c viruses.
This dose was selected because, according to preliminary
experiments, it corresponded to 0.1 LD50 of the wild-type
WSN (vNA) virus and was sufficient to induce a nonlethal
viral pneumonia in more than 95% of the infected C57BL/6
mice, with maximum pulmonary virus titers observed 4
days after inoculation. In mice infected with the vNA35 or
vNA35-VP0c virus, as for mice infected with wild-type
WSN (vNA) virus, the lungs showed a hepatized aspect,
typical of viral pneumonia (data not shown). Pulmonary
viral loads in mice infected with vNA35 (4.7  1.2
Fig. 3. Multiplication and stability of transfectant influenza viruses with dicistronic NA segments. (A) The plaque phenotype of the indicated transfectant
viruses was assayed on MDCK cells in a standard plaque assay as described under Materials and methods. Cell monolayers were stained with crystal violet
after 3 days of incubation at 35°C and are shown for several independent clones (Cx). (B) The growth properties of the indicated transfectant viruses were
analyzed on MDCK cells. Confluent cell monolayers were infected at an m.o.i. of 0.001. At the indicated time points, the supernatants were collected and
virus titers (PFU/ml) were determined on MDCK cells in a standard plaque assay. (C) At 8 h after infection, mock-infected MDCK cells (dotted line), or
cells infected with wild-type WSN(vNA) (bold line), vNA35-VP0c (dashed line), and vNA35-CAT (solid line) were detached from the plates with the cell
dissociation solution (Sigma) and expression of the NA was determined by labeling the cells with the anti-NA mouse monoclonal antibody 10C9. Bound
antibodies were detected with FITC-labeled anti-mouse IgG antibodies and, after fixation of the cells in PBS-PFA, flow cytometry analysis was performed
on a FACScalibur fluorospectrometer (Becton–Dickinson). (D) Genetic stability of the transfectant viruses. Independent clones (Cx) of vNA35, vNA35-CAT,
and vNA35-VP0c viruses were passaged five to six times on MDCK cells at an m.o.i. of 0.01. The viral RNAs from wild-type vNA or from the first and
last passages of the indicated transfectant viruses were analyzed by RT-PCR using the NA//1085 and NA/NC/5 oligonucleotide primers. The position of
the primers is indicated by solid arrows on a schematic drawing of the vNA35-CAT vRNA. Corresponding plasmid DNAs were amplified in parallel. The
amplified products were analyzed on a 1% agarose gel and visualized by ethidium bromide staining. MW: molecular weight markers; the size (bp) is indicated
in the middle. Ø: amplification of RNA from mock-infected cells. (E) The plaque phenotype of the wild-type WSN (vNA) and recombinant vNA35-CAT
and vNA37-CAT viruses was compared on MDCK cells. Cell monolayers were stained with crystal violet after 3 days of incubation at 35°C and are shown
for one representative clone.
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log10PFU) or vNA35-VP0c (4.8  0.3 log10PFU) were
slightly but significantly lower than those observed for mice
infected with wild-type WSN (vNA) virus (5.9  0.1
log10PFU, P  0.1) (Fig. 6A). These results suggested that
recombinant viruses harboring dicistronic NA segments
could efficiently replicate in the lower respiratory tract of
mice.
Furthermore, RT-PCR analysis of the viruses recovered
from the lung homogenates of infected mice was performed.
As shown in Fig. 6B, vNA35 and vNA35-VP0c retained the
foreign inserted sequences upon multiplication in the lungs
of infected mice. Sequencing of the corresponding PCR
products did not reveal any mutation in the duplicated 3
promoter, nor in the VP0c ORF, when compared to the
inoculated virus, indicating that dicistronic viruses with a
duplicated internal 3 promoter were genetically stable in
vivo.
Since the vNA35-CAT replicated less efficiently in cell
culture than the vNA35-VP0c, we compared their replica-
Fig. 4. Analysis of NA viral RNAs in infected cells. Monolayers of MDCK
cells were mock infected or infected with wild-type WSN (vNA) or
transfectant vNA35, vNA35-CAT, or vNA35-VP0c viruses at an m.o.i. of
2 and incubated at 35°C for 8 h. Total cellular RNA was prepared and
analyzed by Northern blot for the presence of vRNAs (A) or cRNAs/
mRNAs (B) with 32P-labeled positive-(A) or negative-(B) sense riboprobes
specific for NA or NP sequences, prior to exposure on a Storm phosphor-
imager (Molecular Dynamics). The position of molecular weight markers
(kb) is indicated. Fig. 5. Expression of the CAT gene by the dicistronic vNA35-CAT virus.
Monolayers of COS-1 cells were mock infected or infected with transfec-
tant vNA35 or vNA35-CAT viruses at an m.o.i. of 2 and incubated at 35°C
for 24 h. Total cellular RNA was prepared and analyzed by Northern blot
for the presence of genomic (closed arrowheads) and subgenomic (open
arrowheads) vRNAs (A) or cRNAs/mRNAs (B) with 32P-labeled positive-
(A) or negative-(B) sense riboprobes specific for CAT sequences, prior to
exposure on a Storm phosphorimager (Molecular Dynamics). The position
of molecular weight markers (kb) is indicated. (C) Cytosolic cell extracts
were prepared at 8 (hatched bars) and 24 (black bars) h after infection and
assayed for CAT levels as described under Materials and methods. Levels
are given in nanograms of CAT protein for 106 infected cells.
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tive potential in vivo. Pulmonary viral loads in mice in-
fected with vNA35-CAT (4.3  0.2 log10PFU) were
slightly lower than those observed for mice infected with
vNA35-VP0c virus (4.6  0.5 log10PFU, P  0.3) (Fig.
6C). RT-PCR analysis of the recovered viruses confirmed
that, despite less efficient replication, the vNA35-CAT virus
was also genetically stable in vivo (data not shown).
Discussion
The rescue of influenza viruses harboring a dicistronic
segment for the expression of heterologous genes has pre-
viously been successful by making use of an IRES which
directs the translation of the foreign protein (Garcia-Sastre
et al., 1994a). In this article, based on the initial observation
from Flick and Hobom (1999), we showed that it is possible
to rescue stable transfectant influenza viruses harboring a
segment made functionally dicistronic at the level of tran-
scription rather than at the level of translation by means of
an internal duplication of the 3 promoter sequence. Indeed,
a recombinant dicistronic vRNA derived from the NA seg-
ment carrying an internal duplication of the 3 promoter
sequence was shown to be transcribed and replicated along
two modes: a genomic mode involving interaction of the 5
promoter with the external 3 promoter sequence, resulting
in the synthesis of full-length genomic mRNA and c/vR-
NAs; and a subgenomic mode involving interaction of the
5 promoter with the internal 3 promoter sequence, result-
ing in the synthesis of subgenomic c/vRNAs and monocis-
tronic mRNA. In addition, the dicistronic segment was
found to be stably maintained upon passage of the recom-
binant virus in cell culture as well as in vivo in mice and to
direct expression of heterologous sequences.
Whereas in a transient replication assay similar amounts
of genomic and subgenomic RNA molecules were detected,
upon infection with the recombinant viruses the genomic
RNA molecules were predominant. This suggested that rep-
lication and/or transcription from the internal 3 promoter
was less efficient in the context of the infected cell than
Fig. 6. Multiplication of dicistronic transfectant viruses in mice. Groups of
five C57BL/6 mice were infected intranasally with 103 PFU of the indi-
cated viruses. Four days after the inoculation, mice were euthanized and
lung homogenates were prepared and titrated for virus by plaque assay on
MDCK cells, as described under Materials and methods (A). Viral titers
were expressed as log10 (PFU/lungs) for individual mice. The titration limit
is indicated by the dotted line. Viral RNAs from the inoculated viruses
(inoc.) or from viruses recovered from the lungs of individual mice (1–5)
were extracted and analyzed by RT-PCR using the NA//1085 and NA/
NC/5 oligonucleotide primers (B). The position of the primers is indicated
by solid arrows on a schematic drawing of the vNA35-VP0c vRNA. The
amplified products were analyzed on a 1% agarose gel and visualized by
ethidium bromide staining. MW: molecular weight markers; the size (kb)
is indicated on the right. Ø: amplification of RNA from mock-infected
mice. Data shown are from one experiment representative of two. In a
separate experiment, groups of seven C57BL/6 mice were infected intra-
nasally with 103 PFU of wild-type WSN (vNA) or dicistronic vNA35-
VP0c or vNA35-CAT viruses. Pulmonary viral loads were determined 4
days after the inoculation, as described above (C).
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when functional RNPs were reconstituted following trans-
fection of the four core proteins. This could be due to
modulation of the properties of the polymerase complex by
some viral, or virus-induced, factors in the infected cell that
could increase its requirement for interaction with both
termini of the genomic RNA. Another possibility could be
that regulatory or packaging sequences are located within
the viral coding sequences, as was shown for several posi-
tive-strand RNA viruses (Fosmire et al., 1992; McKnight
and Lemon, 1996; Weiss et al., 1994) or suggested by the
analysis of influenza DI RNAs (Duhaut and Dimmock,
2000, 2002; Odagiri and Tashiro, 1997). Such sequences if
present on the genomic vRNA but lacking on the sub-
genomic vRNA could account for the observed differences
in the relative levels of subgenomic versus genomic RNAs
between transfected and infected cells. This raises the ques-
tion of the origin of the subgenomic RNA molecules. These
could be generated by internal initiation from genomic
vRNA and could also subsequently result from amplifica-
tion by the viral polymerase. Similarly, subgenomic mR-
NAs may result from either internal initiation reactions
during transcription of the genomic vRNA or transcription
of subgenomic vRNA. Kinetic studies of the synthesis of the
different RNA species in either transfected or infected cells
may help solve this question. In addition, it remains to be
determined whether upon passage of the recombinant vi-
ruses, subgenomic RNAs arise by internal initiation on the
dicistronic vRNA at each viral cycle or alternatively result
from amplification of subgenomic vRNA molecules that
could be packaged in the viral particles. Preliminary data
(not shown) indicating that subgenomic vRNAs could be
detected in purified virions suggested that the subgenomic
RNAs could be replicated and maintained as an additional
segment in the virus progeny.
The recombinant viruses harboring a dicistronic RNA
segment showed an altered phenotype in terms of plaque
size and virus multiplication. This could be correlated with
the reduced steady-state levels of NA vRNA and c/mRNA
and also with the reduced steady-state levels of neuramin-
idase in cells infected with the vNA35-CAT and vNA35-
VP0c viruses as compared to the wild-type (Fig. 3C and 4).
It is likely that the lower levels of the NA vRNA in cells
infected with the dicistronic viruses resulted in a reduced
packaging of this segment into budding viral particles and
therefore suboptimal yields of infectious particles. In addi-
tion, since the NA is involved in the release of virus parti-
cles from infected cells (Palese and Compans, 1976), re-
duced expression of the NA may hamper propagation of the
recombinant dicistronic viruses. Viruses expressing reduced
NA levels have been shown to have altered growth proper-
ties (Fodor et al., 1998) and to be attenuated in mice (So-
lorzano et al., 2000). In this study, the viral load in the lungs
of mice inoculated with the recombinant vNA35-VP0c or
vNA35-CAT viruses was found to be significantly reduced
as compared to that of the wild-type (wt) virus.
Reduced steady-state levels of NA vRNA and c/mRNA
suggested that the overall efficiency of RNA syntheses from
the NA segment was diminished as a result of the insertion
of the foreign sequences (Fig. 4). This could not be attrib-
uted to the presence of the 3 internal promoter sequence
itself as viruses harboring similar dicistronic segments but
lacking the internal 3 promoter sequence (NA37 con-
structs) had similarly altered growth properties (Fig. 3E).
More likely, the altered phenotype could be related to the
increased size of the NA segment. Indeed, reduction in NA
RNA levels, plaque size, and virus growth were more pro-
nounced in the case of vNA35-CAT (2104 nt) than for
vNA35-VP0c (1750 nt) as compared to vNA35 (1445 nt) or
wild-type WSN (1409 nt). Such size effect may also account
for the fact that a transfectant vNA35-GFP virus (2164 nt)
could not be rescued. Rather than the overall size, insertion
of the foreign sequences may affect the proper assembly of
functional RNPs, as it has been shown that model RNAs,
the length of which is a multiple of 48 nt, are replicated
more efficiently (Ortega et al., 2000). In our case, based on
the length of the different NA segments no obvious corre-
lation of that sort could be made. However, as previously
suggested by Ortega et al., such effect could be more pro-
nounced for smaller size RNAs and may not strictly apply to
the longer genomic RNAs (Ortega et al., 2000). Improper
encapsidation could therefore contribute to explain why
replication of subgenomic vRNA is less efficient in infected
cells than replication of full-length genomic NA vRNA
(Fig. 5). In addition to the size effects, alteration of viral
growth and unefficient replication of subgenomic vRNAs
may be related to the nature of the inserted sequences.
Indeed, it has been shown that the noncoding extremities of
each vRNA segment are specific to the ORFs they contain
(Zheng et al., 1996). Therefore, the reconstitution of a fully
functional promoter in the context of the infected cells may
be dependent on the nature of the inserted sequences. In this
respect it is interesting to note that, whereas the GC content
of the NA ORF is 44% the GC content of the CAT and
VP0c ORF were in the same range (45 and 48%, respec-
tively), while the GC content of the GFP ORF was notably
higher (62%), which may contribute to the fact that a
vNA35-GFP virus could not be rescued. The average GC
content of the WSN virus genome segments is 43.9  1.5%
and sequences with notably higher GC content may not be
efficiently replicated or transcribed by the viral polymerase.
The recombinant dicistronic viruses were found to be
stable as they retained the inserted sequences upon succes-
sive passages in cell culture and the frequency of mutations
detected within the inserts fell within the expected range of
the mutational rate of the influenza polymerase (0.68–3.2
105, as measured by Parvin et al., 1986; Stech et al., 1999;
Suarez-Lopez and Ortin, 1994). Nevertheless, the possibil-
ity that mutations resulting in increased expression of the
NA could arise upon propagation of the recombinant viruses
was investigated. No mutations within the noncoding se-
quences could be detected after five passages of the viruses,
except for one clone of vNA35-CAT, which harbored an
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A-to-G mutation at position 17 of the genomic 3, NCR. This
mutation did not seem to result in improved growth prop-
erties nor in increased expression of the NA (data not
shown). The possibility that substitutions in the noncoding
regions of the NA segment could improve transcription
and/or replication of the genomic NA segment and hence
result in increased expression of the NA was therefore
considered. Based on the promoter “up” effect of substitu-
tions in the 3, NCR of the HA segment of the A/Victoria/
3/75 (H3N2) virus for the polymerase complex of the
A/FPV/Bratislava virus (Neumann and Hobom, 1995), we
introduced the corresponding mutations, i.e., G3A, U5C,
and C8U substitutions, in the external 3 promoter of the
dicistronic NA35-CAT segment. No viable transfectant vi-
ruses harboring these substitutions could be rescued, which
could be related to the fact that the promoter up effect was
recently shown to depend on the origin of the polymerase
complex (Crescenzo-Chaigne et al., 2002). It will be of
interest to determine whether the introduction of other sub-
stitutions in the external 3 promoter sequence could result
in preferential transcription and/or replication of the
genomic segment over that of the subgenomic segment, and
hence improve growth of the dicistronic viruses without
impairing expression of the foreign sequences. Yet other
mutations may potentially compensate for the reduced NA
levels produced by the recombinant dicistronic viruses de-
scribed here. These could be located in the NA ORF, re-
sulting in an increased activity of the NA, or even in the HA
gene, resulting in a decreased dependence on NA activity as
shown for instance in the case of viruses resistant to an-
tineuraminidase inhibitors (Gubareva et al., 1996).
In comparison with strategies that rely on the expression
of fusion proteins (Ferko et al., 2001; Percy et al., 1994;
Takasuka et al., 2002), recombinant dicistronic viruses with
an internal 3 promoter duplication allow expression of
native proteins devoid of additional sequences and permit a
minimal increase in the length of the recombinant segments.
Although expression of foreign proteins in their native form
could also be achieved from a dicistronic segment with an
inserted IRES and a second translational unit (Garcia-Sastre
et al., 1994a), this latter strategy is likely to be hampered by
the highly structured nature of the IRES sequence as well as
by size constraints that could limit the replication efficiency
of the recombinant segments. Thus, the largest foreign
polypeptides reported to be expressed using this approach
did not exceed 91 aa when using the human Bip IRES to
express the NA (Garcia-Sastre et al., 1994a) or 125 aa when
the foreign ORF was placed under the control of the IRES
of the EMCV (Garcia-Sastre et al., 1994b). Similarly, when
using the Bip IRES to direct expression of the NA from a
dicistronic segment, we were able to rescue transfectant
viruses expressing the VP0c fragment (101 aa), but not
those expressing the longer CAT or GFP proteins (A. Vieira
Machado and N. Escriou, unpublished observations). As
noted earlier, size constraints might also apply to dicistronic
segments with an internal 3 promoter duplication, but as
shown here expression of the 219-aa-long CAT protein
could be achieved by this approach. Even greater coding
capacity can be expected from smaller segments such as the
M or NS segment. However, it remains to be determined
whether dicistronic vRNA molecules with a duplicated 3
NC region and inserted foreign sequences can be engineered
from these segments without interfering with the alternative
splicing of the mRNA required for expression of the M2 and
NS2 proteins, respectively.
Finally, this novel type of recombinant influenza virus
could have several potential applications. The possibility of
using such dicistronic constructs for an indirect selection of
any foreign or mutated viral gene to be incorporated into
recombinant influenza viruses has been suggested previ-
ously (Flick and Hobom, 1999). In that case the gene which
is to be maintained as a subgenomic vRNA should be placed
under the control of the internal 3 promoter sequence,
whereas the selectable gene that will ultimately be lost
should be located in the 3 proximal position of the vRNA.
The dicistronic viruses described here essentially exhibit the
opposite arrangement and were designed in such a way that
the dicistronic segment will be maintained upon passages.
Since such recombinant dicistronic viruses were found to be
stable both in vitro in cell culture and in vivo in mice, they
could represent a new way of producing live-recombinant
vaccines against respiratory or other pathogens for humans.
Attenuated influenza viruses such as the cold-adapted influ-
enza virus strains that are currently being considered for the
production of a live-attenuated influenza vaccine (Beyer et
al., 2002) could prove useful as vectors for that purpose.
Materials and methods
Cells and viruses
MDBK and MDCK cells were grown at 37°C under 5%
CO2 in complete Dulbecco’s modified Eagle’s medium
(DMEM) with 1 mM sodium pyruvate, 4.5 mg/ml L-glu-
cose, 100 U/ml penicillin, and 100 g/ml streptomycin,
supplemented with 5% heat-inactivated fetal calf serum
(FCS) (TechGen). COS-1 cells were grown in complete
DMEM supplemented with 10% FCS.
Influenza virus A/WSN/33 (WSN, H1N1) and the
WSN/HK (H1N2) reassortant were kindly provided by Dr.
Peter Palese (Mount Sinaı¨ School of Medicine, New York,
USA). Viral stocks were produced by serial allantoic pas-
sage on 11-day-old embryonated hen’s eggs.
Construction of transfer plasmids for reverse genetics
For the construction of transfer plasmids, cDNAs corre-
sponding to wild-type or recombinant NA segments of the
WSN influenza virus were cloned in negative-sense orien-
tation into the polymerase I (pol I) expression plasmid
pPR7, which contains a truncated human RNA polymerase
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I promoter and the hepatitis  virus ribozyme and allows the
synthesis of a viral RNA-like transcript in transfected cells
(Crescenzo-Chaigne et al., 1999).
Briefly, the entire NA segment cDNA was amplified by
PCR with the PWO polymerase (Roche) using plasmid
pT3NAM1 (kindly provided by Dr. Peter Palese; Garcia-
Sastre et al., 1994a) as a template and oligonucleotides
5-AGCAAAAGCAGGAGTTTAAATG-3 and 5-AGTA-
GAAACAAGGAGTTTTTTGAAC-3. The pPR-NA plas-
mid was obtained by insertion of the resulting DNA frag-
ment (in negative-sense polarity) between the two Klenow-
treated BbsI sites of plasmid pPR7.
The pPR-NA35 plasmid was constructed in two steps.
First, a recombinant viral cDNA fragment was generated by
PCR with the Expand high fidelity polymerase mix (Roche)
using plasmid pT3NAM1 as a template and oligonucleo-
tides 5AGCAAAAGCAGGAGTTTAAATG-3 and 5-
AGTAGAAACAAGGAGTTTTTT GAACAAAGCTAGC-
TCTCGAGTTAAACTCCTGCTTTTGCTAGATCTACTT-
GTCAA TGGTGAACGGCAACTCAGC-3 and was in-
serted at the HindII site of plasmid pUC19, yielding plasmid
pUCNA35. The latter plasmid was used as a template for
a second PCR reaction with oligonucleotides 5-
GACGGTCTCTGGCCAGCAAAAGCAGGAGTTTAAA-
TGAATC-3 and 5-GACGGTCTCATATTAGTAGAAA-
CAAGGAGTTTTTTGAACA-3, which included a BsaI
restriction enzyme site (underlined). The amplified product
was digested with BsaI and then cloned between the two
BbsI sites of plasmid pPR7, yielding plasmid pPR-NA35.
For cloning purposes, the coding sequences of the
CAT and GFP, as well as the VP0c fragment encoding aa
157–249 of the Mengo virus VP0 polypeptide, were am-
plified by PCR using plasmids pPOL1-CAT-RT (Ple-
schka et al., 1996), pEGFP-N1 (Clontech), and pM16.1
(Duke and Palmenberg, 1989) as respective templates
with oligonucleotides designed so that the resulting DNA
fragments included a XhoI site before the initiation codon
and a NheI site after the termination codon, and, for the
VP0c fragment, a stretch of six histidines after the initi-
ating methionine. The resulting amplicons were cloned
between the XhoI and NheI sites of plasmid pPR-NA35,
yielding plasmids pPR-NA35-CAT, pPR-NA35-GFP,
and pPR-NA35-VP0c, respectively.
The pPR-NA37, pPR-NA37-CAT, and pPR-NA37-GFP
plasmids were obtained by removing the internal 3 viral
promoter from plasmids pPR-NA35, pPR-NA35-CAT, and
pPR-NA35-GFP, respectively, by digestion with BglII and
XhoI, Klenow filling, and ligation. The coding sequences of
the VP0c polypeptide were inserted into the pPR-NA37
plasmid in the same manner as for plasmid pPR-NA35 (see
above), yielding plasmid pPR-NA37-VP0c.
All constructs were verified by the sequencing of posi-
tive clones using a Big Dye terminator sequencing kit and
an ABI377 automated sequencer (Perkin–Elmer).
Production of recombinant viruses by reverse genetics
The procedures used for the production of the recombi-
nant influenza viruses by reverse genetics were as described
previously by Pleschka et al. (1996). Briefly, each of the
purified pol I transfer plasmids (1 g) was transfected into
a subconfluent monolayer of COS-1 cells (3  105 cells in
35-mm dishes) together with plasmids pHMG-NP (2 g),
pHMG-PA (1 g), pHMG-PB1 (1 g), and pHMG-PB2 (1
g) by using 10 l of Fugene6 reagent (Roche) according to
the manufacturer’s recommendations. pHMG plasmids
were kindly provided by Dr J. Pavlovic (Institute fu¨r Mediz-
inische Virologie, Zurich, Switzerland). After 24 h of incu-
bation at 35°C, the cells were infected at an m.o.i. of 1 with
the WSN/HK helper virus and incubated at 35°C for two
more days in complete DMEM with 2% FCS. The recov-
ered viruses were amplified once on MDCK cells, and the
efficiency of the reverse genetics was evaluated by titration
on MDBK cells after this initial amplification. The forma-
tion of plaques in MDBK cells indicated the presence of
transfectant virus that contained the WSN NA gene, since
the WSN-HK helper virus cannot form plaques in MDBK
cells in the absence of an exogenous source of protease
(Schulman and Palese, 1977). Next, the transfectant viruses
were plaque purified twice on MDBK cells before final
amplification on MDBK cells (viral seed stock p0). Subse-
quent passages (p1, p2, . . .) of the recombinant viruses were
performed at an m.o.i. of 0.01 on MDCK cells for 3 days at
35°C in complete DMEM with 2% FCS. All viral stocks
were titrated on MDCK cell monolayers, in a standard
plaque assay using an agarose overlay in complete DMEM
with 2% FCS.
Analysis of CAT expression in transfected or infected
cells
For the transient expression assay, subconfluent mono-
layers of COS-1 cells (3  105 cells in 35-mm dishes) were
transfected using the Fugene6-mediated method (Roche)
with a mixture of plasmids pcDNA-NP, pcDNA-PA,
pcDNA-PB1, and pcDNA-PB2 (2, 1, 1, 1 g) together with
1 g of plasmid pPR-NA35-CAT or pPR-NA37-CAT.
pcDNA plasmids were kindly provided by Dr G. Brownlee
(Sir William Dunn School of Pathology, Oxford, UK). Cells
were incubated at 35°C in complete DMEM with 10% FCS.
At 48 h posttransfection, cell extracts were prepared in 500
l of lysis buffer and tested for CAT levels using the CAT
ELISA kit (Roche). The lower limit of CAT detection was
0.05 ng/ml.
Alternatively, confluent monolayers of COS-1 cells
were infected with recombinant or wild-type influenza
viruses at an m.o.i. of 2. At 8 or 24 h after infection, cell
extracts were prepared and assayed for CAT levels as
described above.
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Analysis of NA expression in transfected or infected cells
MDCK cells grown in 35-mm dishes were infected with
either recombinant or wild-type WSN viruses at an m.o.i. of
2. COS-1 cells were transfected as described above. At 8 h
after infection or 48 h after transfection, cells were detached
using the cell dissociation solution (Sigma) and incubated
for 30 min at 4°C in 100 l of PBS-BSA (PBS with 0.02%
NaN3 and 1% BSA) containing the mouse monoclonal an-
tibody 10C9 (1:1000 dilution), which is specific for the
WSN-NA protein (kindly provided by Dr. Peter Palese;
Percy et al., 1994). After two washes in PBS–0.02% NaN3,
the cells were incubated for 30 min at 4°C in 100 l of
PBS–BSA containing 2.5 g/ml of FITC-conjugated anti-
mouse IgG antibodies (Becton Dickinson). Finally, cells
were washed twice in PBS, fixed with 100 l of PBS, and
1% paraformaldehyde and analyzed for fluorescence inten-
sity on a FACScalibur fluorocytometer (Becton Dickinson).
Viral RNA extraction, RT-PCR analysis, and sequencing
Viral RNA was extracted with Trizol-LS reagent (Life
Technologies) from 250 l of cell-free supernatant accord-
ing to the manufacturer’s recommendations. The RNA was
resuspended in 20 l of RNAse-free water, and 5 l was
used for reverse transcription by Avian Myeloblastosis Vi-
rus (AMV) reverse transcriptase (RT, Promega) using the
plus-sense primer uni-1 (5-AGCAAAAGCAGG-3) com-
plementary to the last 12 conserved bases of the 3 terminus
of all viral genomic segments (Robertson, 1979). These
cDNAs and the corresponding plasmid DNAs were used as
templates for PCR reactions using the Taq DNA polymerase
(Roche) with primers spanning cDNA nucleotides 1085 to
1108 (NA//1085) and complementary to nucleotides 1385
to 1409 (NA/NC/5) of the NA segment. The RT-PCR
products were analyzed on a 1% agarose gel and visualized
by ethidium bromide staining. For assessing the presence of
mutations, they were purified using a QIAquick PCR puri-
fication kit (Qiagen) and the nucleotide sequences were
determined using internal oligonucleotides, a Big Dye ter-
minator sequencing kit, and an AB1377 automatic se-
quencer (Applied Biosystems).
Sequencing of the 5 termini of the NA genomic RNA
segment was performed using an oligonucleotide/cDNA
ligation strategy (Kolykhalov et al., 1996; Troutt et al.,
1992). Briefly, viral genomic RNA was subjected to reverse
transcription as described above, using as primers oligonu-
cleotides of positive polarity specific of the CAT or NA
coding sequences and located around 300 bp downstream of
the 5 end. The cDNAs were purified using a PCR Purifi-
cation Kit (Qiagen) and ligated to a phosphorylated oligo-
nucleotide tag (5-GACTGTTGTGGCCTGCAGGGC-
CGAATT-3) with an amino group on the 3 terminus using
the T4 RNA ligase (Biolabs). One-tenth of this reaction was
used for a nested PCR amplification. A first round of am-
plification was performed using primer RC1 (5-AATTCG-
GCCCTGCAGGCCACAA-3) complementary to the tag
together with an oligonucleotide of positive polarity specific
of the CAT or NA coding sequences and located around 250
bp downstream of the 5 end. A second round of amplifi-
cation was performed after a 1:25 dilution step, using more
proximal segment-specific primers together with primer
RC2 (5-GCCCTGCAGGCCACAACAGTC-3) comple-
mentary to the tag. Sequencing of the amplified products
was performed with an internal oligonucleotide, using the
protocol described above. The exact sequences of the prim-
ers used for amplification and sequencing of the 5 end of
each recombinant NA segment can be obtained from the
authors upon request.
For sequencing of the 3 termini, 10 l of viral RNA was
polyadenylated using the yeast poly(A) polymerase (Amer-
sham Pharmacia Biotech). Complementary DNAs were pre-
pared by reverse transcription of the polyadenylated RNAs
using an anchored oligo (dT) primer (5-AGATGAATTCG-
GTACC(T)14-3). PCR amplification was performed with
the AmpliTaq DNA Polymerase (Perkin–Elmer), using the
anchored oligo (dT) primer together with a primer of neg-
ative polarity specific for the NA coding sequences and
located about 400 bp (5-CCCTATAAGGGCTTCTGTC-
CTT-3) upstream of the 3 end of the NA segment vRNA.
Forty cycles were performed, each consisting of 30 s at
94°C, 30 s at 55°C, and 30 s at 72°C. For some viruses, a
second round of amplification was performed using a more
proximal primer (5-GGTCCTGCATTCCAAGTGAGA-
ACA-3) again together with the anchored oligo (dT)
primer. The PCR products were purified using a PCR pu-
rification kit (Qiagen) and sequenced with an internal oli-
gonucleotide (5-TTGAGTCCTGCCCAGCAACAAC-3),
using the protocol described above.
Northern blot analysis
COS-1 or MDCK cells grown in 35-mm dishes were
either infected with recombinant or wild-type WSN viruses
at an m.o.i. of 2 or transfected using the Fugene6-mediated
method (Roche) as described above. At 8 or 22 h postin-
fection or 48 h posttransfection, cells were washed twice in
PBS and total cellular RNAs were isolated by Trizol ex-
traction (Life Technologies) according to the manufactur-
er’s recommendations. When RNA was prepared from
transfected cells, RNA extraction was followed by digestion
with 8 units of DNase I (Ambion) in 60 l of 10 mM
Tris–HCl pH 7.5, 2.5 mM MgCl2, 0.1 mM CaCl2 for 60 min
at 37°C, phenol extraction, and isopropanol precipitation.
After denaturation at 70°C in 50% formamide, 2.2 M
formaldehyde, 1 running buffer (40 mM MOPS, 10 mM
sodium acetate, 2 mM EDTA, pH 7.0), samples (2 g) were
run on a 1.2% agarose–0.6 M formaldehyde gel, blotted
onto a nylon membrane (Hybond N, Amersham), and hy-
bridized with a NA-, NP-, or CAT-specific 32P-labeled ri-
boprobe allowing the detection of RNAs of either negative
(vRNAs) or positive (cRNAs, mRNAs) polarity. Hybridiza-
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tions were performed at 65°C in a 50% formamide, 5
SSC, 5 Denhardt, 0.5% SDS solution. The membranes
were washed three times in 2 SSC, 0.1% SDS at room
temperature, and another three times in 0.1 SSC, 0.1%
SDS at 75°C. Finally, the membranes were exposed on a
STORM 820 phosphorimager (Molecular Dynamics) and
analyzed using the Image Quant program (Molecular Dy-
namics).
Infection of mice
C57BL/6 male mice (IFFA CREDO), 7 to 8 weeks of
age, were lightly anesthetized with 100 mg/kg of ketamine
(Merial) and inoculated intranasally with 103 PFU of trans-
fectant or wild-type WSN virus in 40 l of PBS. Four days
postinfection, mice were sacrificed and lung homogenates
were prepared in PBS (3 ml) and titrated for virus on
MDCK cell monolayers, in a standard plaque assay. Statis-
tical analyses were performed on the log10 of the viral titers
measured for individual mice using the Student’s indepen-
dent t test, with the assumptions used for small samples
(normal distribution of the variable, same variance for the
populations to be compared). Viral RNA was extracted with
Trizol-LS reagent (Life Technologies) from 250 l of lung
homogenates according to the manufacturer’s recommenda-
tions and analyzed by RT-PCR and sequencing as described
above.
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